Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 701–800 of 1,726
Efthimiopoulos, S., Vassilacopoulou, D., Ripellino, J. A., Tezapsidis, N., & Robakis, N. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8046 · Cited by 63
Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
Price, D. L., Borchelt, D. R., & Sisodia, S. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6381 · Cited by 59
Maltese, W. A., Wilson, S., Tan, Y., Suomensaari, S., Sinha, S., Barbour, R., & McConlogue, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007238200 · Cited by 59
Self-citationUnifying features of systemic and cerebral amyloidosis
Ghiso, J. A., Wısnıewskı, T., & Frangione, B. (1994) · Molecular Neurobiology · doi:10.1007/bf02778007 · Cited by 69
Soto, C., & Frangione, B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11299-c · Cited by 60
Interaction of Transthyretin with Amyloid β‐Protein: Binding and Inhibition of Amyloid Formation
Schwarzman, A. L., & Goldgaber, D. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514924.ch10 · Cited by 61
Fujiyoshi, M., Tachikawa, M., Ohtsuki, S., Ito, S., Uchida, Y., Akanuma, S., Kamiie, J., Hashimoto, T., Hosoya, K., Iwatsubo, T., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07311.x · Cited by 58
“The brain interstitial fluid (ISF) is in direct contact with CSF and the soluble Ab forms are present in normal human CSF (Seubert et al. 1992; Shoji et al. 1992).”
BackgroundCo‐incorporation of Aβ40 and Aβ42 to form mixed pre‐fibrillar aggregates
Frost, D., Gorman, P. M., Yip, C. M., & Chakrabartty, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03415.x · Cited by 59
Lichtlen, P., & Mohajeri, M. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05064.x · Cited by 59
Cerebrospinal fluid inhibits Alzheimer β‐amyloid fibril formation in vitro
Wisniewski, T., Castano, E., Ghiso, J., & Frangione, B. (1993) · Annals of Neurology · doi:10.1002/ana.410340422 · Cited by 59
Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers.
Hughes, S. R., Goyal, S., Sun, J., Gonzalez‐DeWhitt, P. A., Fortes, M. A., Riedel, N. G., & Sahasrabudhe, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2065 · Cited by 69
Strazielle, N., Ghersi-Egea, J.-F., Ghiso, J., Dehouck, M.-P., Frangione, B., Patlak, C., Fenstermacher, J., & Gorevic, P. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.29 · Cited by 59
“When luminal peptide concentration was 3 nM, a concentration approximating that in normal blood (5, 6), the luminal-to-abluminal flux of TCA-precipitable I-sAb across the filter plus cells was larger than that of PEG.”
BackgroundMethodBapineuzumab: Anti-β-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer‘s Disease
Panza, F., Frisardi, V., Imbimbo, B. P., D‘Onofrio, G., Pietrarossa, G., Seripa, D., Pilotto, A., & Solfrizzi, V. (2010) · Immunotherapy · doi:10.2217/imt.10.80 · Cited by 59
Refolo, L. M., Sambamurti, K., Efthimiopoulos, S., Pappolla, M. A., & Robakis, N. K. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400515 · Cited by 59
Magnetic Resonance Spectroscopic Changes in Alzheimer's Diseasea
PETTEGREW, J. W., KLUNK, W. E., PANCHALINGAM, K., McCLURE, R. J., & STANLEY, J. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48480.x · Cited by 59
Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 61
Microvascular damage and platelet abnormalities in early Alzheimer's disease
Borroni, B., Akkawi, N. M., Martini, G., Colciaghi, F., Prometti, P., Rozzini, L., Luca, M. D., Lenzi, G. L., Romanelli, G., Caimi, L., et al. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00289-7 · Cited by 57
Cerebrospinal fluid Ab40 and Ab42 natural course and clinical usefulness
Shoji, M. (2002) · Frontiers in Bioscience · doi:10.2741/a826 · Cited by 57
Living with the enemy: a physiological role for the β-amyloid peptide
Esteban, J. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.10.008 · Cited by 66
Axelman, K., Basun, H., Winblad, B., & Lannfelt, L. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540240037013 · Cited by 57
Mazur‐Kolecka, B., Frackowiak, J., & Wísniewski, H. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00873-o · Cited by 69
Watson, D. J., Selkoe, D. J., & Teplow, D. B. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400703 · Cited by 57
Self-citationHIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin
András, I. E., Eum, S. Y., Huang, W., Zhong, Y., Hennig, B., & Toborek, M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.11.004 · Cited by 56
“In contrast, Aβ(1–42) is found more frequently in senile plaques (Seubert et al., 1992).”
BackgroundNeurodegeneration and Alzheimer’s disease: the lesson from tauopathies
Sorrentino, G., & Bonavita, V. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0789-x · Cited by 66
“Aβ appears to be toxic in different models in vivo and in vitro but generally the concentrations of Aβ required to induce neuronal death appear excessive [27].”
BackgroundPharmacotherapeutic targets in Alzheimer's disease
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00595.x · Cited by 57
Savage, M. J., Iqbal, M., Loh, T., Trusko, S. P., Scott, R., & Siman, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90490-1 · Cited by 42
α2-Macroglobulin-Mediated Degradation of Amyloid β1–42: A Mechanism to Enhance Amyloid β Catabolism
Lauer, D., Reichenbach, A., & Birkenmeier, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7569 · Cited by 65
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 62
Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease.
MORI, H., ISHII, K., TOMIYAMA, T., FURIYA, Y., SAHARA, N., ASANO, S., ENDO, N., SHIRASAWA, T., & TAKIO, K. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.251 · Cited by 56
Mustafa, M. K., Nabok, A. V., Parkinson, D., Tothill, I. E., Salam, F., & Tsargorodskaya, A. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.07.042 · Cited by 55
Primate-like amyloid-β sequence but no cerebral amyloidosis in aged tree shrews
Pawlik, M., Fuchs, E., Walker, L. C., & Levy, E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00017-2 · Cited by 56
Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets
Smith, C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00738-6 · Cited by 56
Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transfer
Huang, T. H. J., Fraser, P. E., & Chakrabartty, A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1050 · Cited by 63
Kimura, N., Takahashi, M., Tashiro, T., & Terao, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20984 · Cited by 59
“Insofar as Ab40 is thought to be the primary form of Ab found in normal brain (Haas et al., 1992; Seubert et al., 1992; Shoji et al., 1992; Busciglio et al., 1993; Vigo-Pelfrey et al., 1993), the Ab40-induced BDNF production from astrocytes that we observed may be one way in which astrocytes maintain normal brain home…”
BackgroundAmyloid-β Fibrillogenesis Seeded by Interface-Induced Peptide Misfolding and Self-Assembly
Chi, E. Y., Frey, S. L., Winans, A., Lam, K. L. H., Kjær, K., Majewski, J. P., & Lee, K. Y. C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.056 · Cited by 54
The Metalloprotease Meprin β Is an Alternative β-Secretase of APP
Becker-Pauly, C., & Pietrzik, C. U. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00159 · Cited by 52
“Indeed, heterogeneity of alternative β-secretase cleavage events has been described (Golde et al., 1992; Haass et al., 1992b; Seubert et al., 1992; Busciglio et al., 1993) leading to alternative Aβ peptides other than Aβ1/11-x (Vigo-Pelfrey et al.”
BackgroundActivation of Muscarinic Receptors Inhibits औ-Amyloid Peptide-induced Signaling in Cortical Slices
Gu, Z., Zhong, P., & Yan, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209892200 · Cited by 56
NAP Mechanisms of Neuroprotection
Gozes, I., Steingart, R. A., & Spier, A. D. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:067 · Cited by 59
“Interactions With the Aβ Peptide The Alzheimer’s disease neurotoxin, the Aβ peptide, tends to create insoluble deposits around the walls of cerebral blood vessels and extracellular neuritic plaques interfering with central nervous system cells (Shoji et al., 1992; Seubert et al., 1992).”
BackgroundThe origin of amyloid in cerebral vessels of aged dogs
Węgiel, J., Wı́sniewski, H. M., Dziewíatkowski, J., Tarnawski, M. J., Nowakowski, J., Dziewia̧tkowska, A., & Sołtysiak, Z. (1995) · Brain Research · doi:10.1016/0006-8993(95)01156-0 · Cited by 55
Eckols, K., Bymaster, F. P., Mitch, C. H., Shannon, H. E., Ward, J. S., & DeLapp, N. W. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02064-p · Cited by 53
Surface Effects Mediate Self-Assembly of Amyloid-β Peptides
Lin, Y., Petersson, E. J., & Fakhraai, Z. (2014) · ACS Nano · doi:10.1021/nn5031669 · Cited by 54
Zhu, X., Bora, R. P., Barman, A., Singh, R. R. P., & Prabhakar, R. S. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp210019h · Cited by 60
Transmembrane Fragment Structures of Amyloid Precursor Protein Depend on Membrane Surface Curvature
Domínguez, L., Meredith, S. C., Straub, J. E., & Thirumalai, D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja410958j · Cited by 56
Interactions of polyunsaturated fatty acids with amyloid peptides Aβ40 and Aβ42
Shatshat, A. E., Pham, A. T., & Rao, P. P. N. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.12.027 · Cited by 59
Amyloid-Beta Mediates Homeostatic Synaptic Plasticity
Galanis, C., Fellenz, M., Becker, D., Bold, C., Lichtenthaler, S. F., Müller, U. C., Deller, T., & Vlachos, A. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1820-20.2021 · Cited by 51
“In comparison, the physiological functions of cleavage products generated along the “amyloidogenic pathway”, which are also produced in low concentrations in the healthy brain (Cirrito et al., 2003; Seubert et al., 1992; Shoji et al., 1992), are incompletely understood.”
BackgroundRelationship Between Multifunctional Protein "Clusterin" and Alzheimer Disease
Choi-Miura, N.-H., & Oda, T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00106-6 · Cited by 60
Peng, Y., Jiang, L., Lee, D. Y. W., Schachter, S. C., Ma, Z., & Lemere, C. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20987 · Cited by 54
“Ab sandwich ELISA was performed as described elsewhere (Seubert et al., 1992; Johnson-Wood et al., 1997).”
MethodMetabolism of the “Swedish” amyloid precursor protein variant in Madin-Darby canine kidney cells.
Lo, A. C., Haass, C., Wagner, S. L., Teplow, D. B., & Sisodia, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47376-0 · Cited by 54
Immunohistochemical distribution of amyloid precursor protein during normal rat development
Ohta, M., Kitamoto, T., Iwaki, T., Ohgami, T., Fukui, M., & Tateishi, J. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90019-7 · Cited by 53
Phosphorylation of Neuronal Cytoskeletal Proteins in Alzheimer's Disease and Lewy Body Dementiasa
Trojanowski, J. Q., & LEE, V. M. ‐. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44403.x · Cited by 63
Mattson, M. P., Cheng, B., & Smith‐Swintosky, V. L. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80035-1 · Cited by 59
Mably, A. J., Liu, W., Mc Donald, J. M., Dodart, J.-C., Bard, F., Lemere, C. A., O'Nuallain, B., & Walsh, D. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.008 · Cited by 53
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before
Mancuso, C., Siciliano, R., Barone, E., Butterfield, D. A., & Preziosi, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.601740 · Cited by 60
“On the basis of this theory, Ab is produced by secretase-mediated cleavages of the amyloid precursor protein (APP) [5-7].”
BackgroundNicolau, C., Greferath, R., Balaban, T. S., Lazarte, J. E., & Hopkins, R. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022627199 · Cited by 52
Bekris, L. M., Galloway, N. M., Millard, S., Lockhart, D., Li, G., Galasko, D. R., Farlow, M. R., Clark, C. M., Quinn, J. F., Kaye, J. A., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.020 · Cited by 54
“Both soluble APP and Aβ are normally present in the brain and CSF (Seubert et al., 1992).”
Self-citationSecreted Forms of the Amyloid-β Precursor Protein Are Ligands for the Class A Scavenger Receptor
Santiago-Garcı́a, J., Mas-Oliva, J., Innerarity, T. L., & Pitas, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102879200 · Cited by 52
Role of Blood Vessels in Producing Pathological Changes in the Brain with Alzheimer's Disease
Miyakawa, T., Kimura, T., Hirata, S., Fujise, N., Ono, T., Ishizuka, K., & Nakabayashi, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06349.x · Cited by 52
Tashima, Y., Oe, R., Lee, S., Sugihara, G., Chambers, E. J., Takahashi, M., & Yamada, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308622200 · Cited by 52
Neurodegenerative Alzheimer-like Pathology in PDAPP 717V → F Transgenic Mice
Games, D., Masliah, E., Lee, M., Johnson‐Wood, K., & Schenk, D. (1997) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-60680-9_8 · Cited by 52
Self-citationPirttilä, T. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020105022 · Cited by 52
Jiang, D., Dinh, K. L., Ruthenburg, T. C., Zhang, Y., Su, L., Land, D. P., & Zhou, F. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8085792 · Cited by 53
The use of mass spectrometry to study amyloid‐β peptides
Grasso, G. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20281 · Cited by 57
Rózga, M., & Bal, W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900358j · Cited by 58
Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer
Jin, W., Bu, X., Liu, Y.-H., Shen, L., Zhuang, Z., Jiao, S., Zhu, C., Wang, Q., Zhou, H., Zhang, T., et al. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9682-9 · Cited by 53
“Amyloid-beta (Aβ) is the initial factor in AD pathogenesis, which is a normal product of amyloid precursor protein (APP) proteolysis by β- or γ-secretase and can be measured in the brain, cerebrospinal fluid, and blood (Haass et al. 1992; Seubert et al. 1992; Shoji et al. 1992).”
BackgroundAttenuated Hippocampus-Dependent Learning and Memory Decline in Transgenic TgAPPswe Fischer-344 Rats
Ruiz-Opazo, N., Kosik, K. S., Lopez, L. V., Bagamasbad, P., Ponce, L. R. B., & Herrera, V. L. M. (2004) · Molecular Medicine · doi:10.2119/2003-00044.herrera · Cited by 50
“The central pathogenic hypothesis of AD focuses on increased Aβ production, however, it is still unknown as to how Aβ causes AD on one hand, and on the other hand, what normal physiological role Aβ performs because Aβ is detected in healthy individuals throughout life (2,3).”
BackgroundGrziwa, B., Grimm, M. O. W., Masters, C. L., Beyreuther, K., Hartmann, T., & Lichtenthaler, S. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210047200 · Cited by 51
Xia, W., Ostaszewski, B. L., Kimberly, W. T., Rahmati, T., Moore, C. L., Wolfe, M. S., & Selkoe, D. J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0322 · Cited by 51
Self-citationThe possible role of the immune system in Alzheimer’s disease
Marx, F., Blasko, I., Pavelka, M., & Grubeck-Loebenstein, B. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00028-x · Cited by 57
Beta‐sheet breaker strategy for the treatment of Alzheimer's disease
Adessi, C., & Soto, C. A. (2002) · Drug Development Research · doi:10.1002/ddr.10074 · Cited by 61
“…peptide (sAb), which is present at similar concentrations in normal and AD cerebrospinal fluid (CSF) and blood, indicating that Ab is a natural rather than a pathogenic product [Seubert et al., 1992; Shoji et al., 1992], and the inhibition of its production may have deleterious consequences.”
Brain Amyloid — A Physicochemical Perspective
Maggie, J. E., & Mantyh, P. W. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00797.x · Cited by 53
Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
Sobów, T., Flirski, M., & Liberski, P. P. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1491 · Cited by 59
“1992) and is secreted into the extracellular space allowing its detection in the CSF and plasma (Seubert et al. 2002).”
BackgroundKowalik‐Jankowska, T., Ruta-Dolejsz, M., Wiśniewska, K., & Łankiewicz, L. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00495-6 · Cited by 52
A specific structural interaction of Alzheimer's peptide Aβ1–42 with α1-antichymotrypsin
Janciauskiene, S. M., Eriksson, S., & Wright, H. T. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-668 · Cited by 54
Farkas, I. G., Czigner, A., Farkas, E., Dobó, E., Soós, K., Penke, B., Endrész, V., & Mihály, A. (2003) · Acta Histochemica · doi:10.1078/0065-1281-00696 · Cited by 53
The role of glycoproteins in neural development, function, and disease
Breen, K. C., Coughlan, C. M., & Hayes, F. D. (1998) · Molecular Neurobiology · doi:10.1007/bf02740643 · Cited by 54
Changes in Protein Kinases in Brain Aging and Alzheimer??s Disease: Implications for Drug Therapy
Jin, L., & Saitoh, T. (1995) · Drugs & Aging · doi:10.2165/00002512-199506020-00006 · Cited by 51
Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides
Forloni, G., Tagliavini, F., Bugiani, O., & Salmona, M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00013-5 · Cited by 52
Fabian, H., Szendrei, G. I., Mantsch, H. H., Greenberg, B., & Ötvös, L. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18811.x · Cited by 52
Kimura, H., & Schubert, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7508 · Cited by 54
The levels of cerebrospinal fluid Aβ40 and Aβ42(43) are regulated age-dependently
Shoji, M., Kanai, M., Matsubara, E., Tomidokoro, Y., Shizuka, M., Ikeda, Y., Ikeda, M., Harigaya, Y., Okamoto, K., & Hirai, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00229-3 · Cited by 50
Mohamadi, R. M., Svobodová, Z., Bı́lková, Z., Otto, M., Taverna, M., Descroix, S., & Viovy, J. (2015) · Biomicrofluidics · doi:10.1063/1.4931394 · Cited by 50
Skaat, H., Shafir, G., & Margel, S. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0276-4 · Cited by 55
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 50
“While Ab deposits were found significantly within neuritic plaques (Glenner and Wong 1984; Selkoe 1996), some studies point out that physiological levels of Ab or related derivatives may play important roles as normal cellular modulators (Whitson et al. 1990; Seubert et al. 1992; Koo et al. 1993) and in rescuing neuro…”
BackgroundRosales‐Corral, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.005 · Cited by 53
“However, Ah25–35 is not found in vivo (Seubert et al., 1992).”
BackgroundDeveloping Preventive Therapies for Chronic Diseases: Lessons Learned from Alzheimer's Disease
Selkoe, D. J. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00370.x · Cited by 50
Self-citationPogocki, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1463 · Cited by 50
Varesio, E., Rudaz, S. L., Krause, K., & Veuthey, J. (2002) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)01241-4 · Cited by 50
Mönning, U., Sandbrink, R., Banati, R. B., Masters, C. L., & Beyreuther, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80514-8 · Cited by 50
Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells
Ida, N., Masters, C. L., & Beyreuther, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00948-9 · Cited by 51
Wallace, W., Lieberburg, I., Schenk, D., Vigo-Pelfrey, C., Davis, K., & Haroutunian, V (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04896.1995 · Cited by 50
Self-citationYang, X., Chen, Y.-H., Liu, L., Gu, Z., You, Y., Hao, J., Sun, N., & Gao, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107357 · Cited by 59
Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing
Somavarapu, A. K., & Kepp, K. P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00208 · Cited by 51
Cu II Binding to Various Forms of Amyloid‐β Peptides: Are They Friends or Foes?
Borghesani, V., Aliès, B., & Hureau, C. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700776 · Cited by 59
Amyloid β-protein stimulates casein kinase I and casein kinase II activities
Chauhan, A., Chauhan, V. P. S., Murakami, N., Brockerhoff, H., & Wísniewski, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90479-7 · Cited by 49
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 66
“Aβ production and secretion has been found to occur readily both in tissue culture (25,26), and in the CNS as evidenced by the presence of Aβ in human as well as rodent cerebral spinal fluid (CSF) (26,27).”
Background(1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.9.937 · Cited by 49
Vaucher, E., Aumont, N., Pearson, D., Rowe, W. B., Poirier, J., & Kar, S. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00120-x · Cited by 55
“These results, together with the evidence that A peptides are produced constitutively by normal brain cells ( Seubert et al., 1992; Selkoe, 1999), suggest a role for these peptides in the regulation of normal cholinergic functions both in young as well as aged rats.”
Dyke, K. V. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90031-1 · Cited by 52
Tang, Y. P., Haslam, S. Z., Conrad, S. E., & Sisk, C. L. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6409 · Cited by 53
Papastoitsis, G., Siman, R., Scott, R. W., & Abraham, C. R. (1994) · Biochemistry · doi:10.1021/bi00167a025 · Cited by 49
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.